3

PRIMARY DOCUMENT

Company: REGENERON PHARMACEUTICALS, INC.
Filed: November 22, 2011
Period of Report: November 18, 2011
Accession Number: 0001237899-11-000068

View Document ↗ View on SEC.gov ↗